title: Highlights from the XII European Cancer Conference Copenhagen, Denmark.
authors.forename: Preeta
authors.initials: P
authors.lastname: Tyagi
authors.forename: Nancy
authors.initials: N
authors.lastname: Price
authors.forename: Kesava
authors.initials: K
authors.lastname: Reddy
authors.forename: Jennifer
authors.initials: J
authors.lastname: Klem
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D000077143:Docetaxel; D006801:Humans; D008297:Male; D008942:Mitoxantrone / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000401:mortality / Q000628:therapy*; D016032:Randomized Controlled Trials as Topic; D043823:Taxoids / Q000627:therapeutic use*; D013792:Thalidomide / Q000627:therapeutic use; D014055:Tomography, Emission-Computed
chemical_list: D020533:Angiogenesis Inhibitors; D000970:Antineoplastic Agents; D000972:Antineoplastic Agents, Phytogenic; D043823:Taxoids; D000077143:Docetaxel; D013792:Thalidomide; D008942:Mitoxantrone